May 20, 2019
Oncopeptides to Apply for Accelerated Approval in the US
Media
May 17, 2019
Camel-IDS appoints Thomas Ramdahl as Independent Director
May 16, 2019
Oncopeptides Announces Acceptance of Four Abstracts Highlighting Melflufen Clinical Programs for Presentation at 24th EHA Congress in June 2019
May 15, 2019
Oncopeptides Announces Melflufen Data Accepted for Presentation at 2019 ASCO Annual Meeting
May 15, 2019
GenSight Biologics reports positive 96-week data from REVERSE Phase III clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)
May 14, 2019
Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update
May 10, 2019
MIPS – World’s First Safety Helmet With MIPS Brain Protection System Released
May 10, 2019
Q1 2019 General Market Overview
May 09, 2019
Pulmonx Closes $65 Million Financing and Adds Chief Financial Officer
May 09, 2019
Targovax ASA: First quarter 2019 results